Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study.
Read MoreADT can cause anemia, but is it iron-deficiency anemia?
Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study.
Read MoreAre there limits on the benefits of exercise for men on ADT?
Effects of six months of aerobic and resistance training on metabolic markers and bone mineral density in older men on androgen deprivation therapy for prostate cancer.
Read MoreIf I go off of ADT, how long should it take for my testosterone levels to return to normal?
Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy.
Read MoreA New Review on Cognitive Function and ADT
Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
Read MoreExercise makes ADT more manageable – but does it matter when you start exercising?
Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.
Read MoreYet again, ADT and Cognitive Decline: Does the Type of ADT Matter?
Different androgen deprivation therapies might have a differential impact on cognition – An analysis from a population-based study using time-dependent exposure model.
Read MoreWhat’s the latest on a possible link between ADT and the risk of dementia?
Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.
Read MoreAnd here's a paper that fails to find an association between ADT and cognitive impairment
Prostate Cancer, Use of Androgen Deprivation Therapy, and Cognitive Impairment: A Population-based Study.
Read MoreMemory and Mood on ADT
Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
Read More